AAL SCIENT INC has a total of 24 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are DITESAN LTD, RACTIGEN THERAPEUTICS and REDBIOTEC AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 3 | |
#5 | China | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Anversa Piero | 24 |
#2 | Leri Annarosa | 14 |
#3 | Kajstura Jan | 2 |
#4 | Perrella Mark | 1 |
Publication | Filing date | Title |
---|---|---|
US2019343888A1 | C-kit-positive bone marrow cells and uses thereof | |
WO2018144689A1 | CARDIAC PROGENITOR CELLS HAVING ENHANCED p53 EXPRESSION AND USES THEREOF | |
CN110167349A | Non- mesenchyma people Lung stem cells and the method that they are used to treat respiratory disorder | |
US2017258853A1 | Pancreatic stem cells and uses thereof | |
CA3017125A1 | Neural stem cells and uses thereof |